STAT4 and primary cutaneous T-cell non-Hodgkin lymphoma: Showe et al. [112] first described the loss of STAT4 expression in SS PBMCs, and Litvinov et al. [113] confirmed that low STAT4 expression in CTCL lesional skin is associated with progressive disease.